Human medicines European public assessment report (EPAR): Viramune, nevirapine, Date of authorisation: 04/02/1998, Revision: 46, Status: Authorised

Submitted by Anonymous (not verified) on 7 April 2026 - 15:42

Human medicines European public assessment report (EPAR): Viramune, nevirapine, Date of authorisation: 04/02/1998, Revision: 46, Status: Authorised

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 37, Status: Authorised

Submitted by Anonymous (not verified) on 7 April 2026 - 15:06

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 7 April 2026 - 15:00

Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Aerinaze, desloratadine,pseudoephedrine, Date of authorisation: 30/07/2007, Revision: 23, Status: Authorised

Submitted by Anonymous (not verified) on 7 April 2026 - 14:24

Human medicines European public assessment report (EPAR): Aerinaze, desloratadine,pseudoephedrine, Date of authorisation: 30/07/2007, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Zokinvy, lonafarnib, Date of authorisation: 18/07/2022, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 7 April 2026 - 14:16

Human medicines European public assessment report (EPAR): Zokinvy, lonafarnib, Date of authorisation: 18/07/2022, Revision: 4, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More